Mutagens and Multivitamins

Not one to shy away from controversy, Bruce Ames has pitted himself against industry groups, environmentalists, and his peers through his work identifying DNA mutagens. And he’s not done yet.

Written byMegan Scudellari
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

BRUCE N. AMESSenior Scientist Children’s Hospital Oakland Research Institute Oakland, California Professor Emeritus University of California, Berkeley© PAUL SIMCOCK PHOTOGRAPHYOn an otherwise ordinary day in 1964, Bruce Ames picked up a box of potato chips and read the list of ingredients. A biochemist at the National Institutes of Health (NIH) in Bethesda, Maryland, Ames spent his days studying mutations in strains of Salmonella, so it wasn’t unusual that he began to wonder if any of the preservatives or chemicals on that long list of ingredients might mutate DNA. Ames decided to use his Salmonella to try to detect genetic damage caused by chemicals. “I figured the world needed some quick, easy test to detect mutagens,” says Ames.

Ames had hundreds of strains of S. typhimurium with mutations in the genes required to produce histidine, a standard amino acid for making proteins. These strains could not grow without the addition of histidine. When millions of bacteria were placed in media lacking the amino acid, however, a few would spontaneously mutate, produce histidine again, and survive as a colony. Ames figured if he added a chemical, such as a potato-chip preservative, to the Salmonella strains, and the chemical increased the number of surviving colonies, it was a mutagen.

“Nutrition is a muddy field, but I like getting into muddy fields.”

Ames began tinkering with the test as a hobby. Then, in 1967, when he moved to the University of California, Berkeley, he got some ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies